Since TGF-β signals may function in potent tumor suppression in normal epithelial cells and in early-stage tumors [11], we speculated that genetic variations in SMAD6 may result in altered gene expression or regulation of signaling function. This evidence concerns the gene SMAD6 and neoplasm.